Fred Hutch Obliteride raises more than $3 million in 2020 Fundraising exceeds organizers’ expectations in unprecedented pandemic era

Fred Hutch-led clinical trial shows new smartphone app helps smokers quit JAMA Internal Medicine study shows iCanQuit app, based on acceptance and commitment therapy, is 1 1/2 times more efficacious than National Cancer Institute QuitGuide app, based on US clinical practice guidelines

Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.

New gene therapy approach eliminates at least 90% latent herpes simplex virus 1 In Nature Communications, Fred Hutch scientists demonstrate in a mouse model how gene therapy could cure an infection that afflicts billions of people

Tip Sheet: COVID-19 vaccines, COVID-19 and cancer patients, smoking cessation apps, structural racism in medicine – and more Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.

Seattle to Glow Orange to Support Fred Hutch Cancer, COVID-19 Research Thousands from around the world are participating in Fred Hutch Obliteride 2020

Fred Hutch joins international COVID-19 vaccine effort New clinical trials network will evaluate vaccines and antibodies to prevent COVID-19

Tip Sheet: SARS-CoV-2 antibodies, COVID-19 and health disparities, eating in tough times and immune protection in breast milk SEATTLE – July 7, 2020 – Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.

Fred Hutch announces reductions in workforce In response to economic impact from COVID-19, Fred Hutch laid off 76 employees from its South Lake Union campus and eliminated 81 open positions

Fred Hutch announces new additions and leadership to board of trustees Kathy Surace-Smith elected as new chair; Leigh Morgan takes on vice chair position; Connie Kravas and Pete Shimer become newest members

Fred Hutch and University of Washington experts: Treat COVID-19 earlier to save lives New review article in Open Forum Infectious Diseases suggests “golden opportunity being missed”

Join Drs. Larry Corey and John Mascola for a discussion on COVID-19 vaccines Hear from two global experts about how existing partnerships, networks and infrastructure can be used to develop, test and distribute vaccines safely and effectively, in record time

Tip Sheet: HIV and COVID-19, antibody interactions, immune responses to colorectal cancer and how Fred Hutch is getting back to work SEATTLE – June 2, 2020 – Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.

Fred Hutch Obliteride changes gears, shifts to individual events for 2020 Obliteride goes global to accelerate cancer and COVID-19 research

Fred Hutch announces new collaboration with Roche leveraging digital technology to help cancer patients undergoing chemotherapy Project will focus on reducing unplanned emergency department visits through a remote monitoring system

Fred Hutch, NIH experts outline plan for COVID-19 vaccines In a Science perspective, experts urge multi-pronged, coordinated approach to successfully develop COVID-19 vaccines

Fred Hutch and the Seattle Cancer Care Alliance awarded Bank of America grant for COVID-19 relief efforts Money will support purchase of medical equipment and testing development

Fred Hutch announces 9 recipients of the Dr. Eddie Méndez award The annual honor recognizes postdoctoral cancer biology researchers from underrepresented minority groups